Pharma Emerging Markets 2.0: How Emerging Markets Are Driving the Transformation of the Pharmaceutical Industry

Download Whitepaper
Pharma Emerging Markets 2.0: How Emerging Markets Are Driving the Transformation of the Pharmaceutical Industry

To better understand both the challenges faced by the global pharmaceutical industry in its pursuit of emerging-market opportunities and the strategies that leaders are employing to address them, Booz & Company surveyed executives from more than 25 of the top pharmaceutical and generics companies, other industry experts, and members of Booz & Company’s global pharmaceutical practice. The results paint a compelling picture of the hurdles and opportunities Pharma faces in pursuing perhaps its best opportunity for growth.

Matthias Buente, Stephan Danner, Susanne Weissbäcker, and Christoph Rammé
Have Your Say
Rate this feature and give us your feedback in the comments section below


Rate this Whitepaper: (4.4 Stars | 59 Votes)


Tags: pharma emerging | pharma emerging markets | emerging markets | Booz & Company | global pharmaceutical industry | Pharma Emerging Markets 2.0


By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product.

To view this FREE whitepaper, register as a Pharma IQ member below.
Or if you're already a Pharma IQ member, sign in to download.

First Name*
Last Name*
Job Title*
Company
Country
State
E-mail*
Phone*
Username*
Password*
Confirm Password*

By clicking Submit, you accept our User Agreement, Privacy Policy, and Cookie Policy.


comments powered by Disqus
You Might Also Like





Advertise With Us

Join the Pharmas IQ Community